2022
Exports
$1.64BWorld Rnk 31 / 223
Flag Rnk 28 / 96
2022
PRODUCT COMPLEXITY IN Pharmaceutical products
1.38Rnk 75 / 1025
2022
Imports
$9.1BWorld Rnk 19 / 226
Flag Rnk 8 / 96
2022
ECONOMIC COMPLEXITY of Brazil
0.36Rnk 49 / 133

About

Exports In 2022, Brazil exported $1.64B in Pharmaceutical products, making it the 31st largest exporter of Pharmaceutical products in the world. At the same year, Pharmaceutical products was the 28th most exported product in Brazil. The main destination of Pharmaceutical products exports from Brazil are: United States ($196M), China ($189M), Argentina ($103M), Mexico ($93.5M), and Colombia ($81.5M).

The fastest growing export markets for Pharmaceutical products of Brazil between 2021 and 2022 were China ($149M), Egypt ($24.7M), and Uruguay ($21.6M).

Imports In 2022, Brazil imported $9.1B in Pharmaceutical products, becoming the 19th largest importer of Pharmaceutical products in the world. At the same year, Pharmaceutical products was the 8th most imported product in Brazil. Brazil imports Pharmaceutical products primarily from: United States ($1.61B), Belgium ($1.18B), Switzerland ($1.12B), Germany ($1.09B), and China ($466M).

The fastest growing import markets in Pharmaceutical products for Brazil between 2021 and 2022 were Belgium ($271M), Germany ($241M), and Switzerland ($173M).

COMPANIES In 2023, leading companies such as CNH Industrial (1) and Dole Fresh Fruit (1) were at the forefront of shipping Pharmaceutical products from Brazil to the United States.

Latest Trends

May 2024

Subnational Monthly Trade

Time Scale
Flow
Color
EXPORT GROWTH (May 2023 - May 2024)$-12.4M(-10.6%)
IMPORT GROWTH (May 2023 - May 2024)$240M(27%)
MAIN EXPORTER (May 2024)São Paulo$67.3M
MAIN DESTINATION (May 2024)United States$11.5M

This section shows Pharmaceutical products's exports and imports data at subnational level for Brazil. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Pharmaceutical products over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$1.64B
IMPORTS (2022)$9.1B
NET TRADE (2022)-$7.46B

In 2022, Brazil exported $1.64B in Pharmaceutical products. The main destinations of Brazil exports on Pharmaceutical products were United States ($196M), China ($189M), Argentina ($103M), Mexico ($93.5M), and Colombia ($81.5M).

In 2022, Brazil imported $9.1B in Pharmaceutical products, mainly from United States ($1.61B), Belgium ($1.18B), Switzerland ($1.12B), Germany ($1.09B), and China ($466M).

Explore Visualizations

Export Destinations (2022)

Import Origins (2022)

Market Growth

Flow
THE FASTEST GROWING Pharmaceutical products EXPORT MARKETS FOR Brazil WERE (2021 - 2022):
China$149M (372%)
Egypt$24.7M (207%)
Uruguay$21.6M (103%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Pharmaceutical products BY Brazil WERE (2021 - 2022):
Czechia-$17.7M (-69.4%)
Germany-$14.5M (-48.1%)
Sweden-$9.71M (-97.1%)

Change in Exports by Market (2021 - 2022)

Market Concentration

View
Flow
Type
In 2022, Brazil's main exporting competitors in Pharmaceutical products were:
In 2022, Brazil's main importing competitors in Pharmaceutical products were:

Explore Visualizations

Trade Value of Pharmaceutical products by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALUnited States+ $195M
TOP IMPORT POTENTIALGermany+ $439M

Pharmaceutical products’s highest export potential is United States. With an export gap of $195M.   Pharmaceutical products’s highest import potential is Germany with an import gap of $439M.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with